Andreas Morguet Selected Research

N(3)- (4- methoxyfumaroyl)- 2,3- diaminopropionic acid

11/2007

Correlation of epicardial and systemic flow-mediated vasodilation in patients with atypical angina but no evidence of atherosclerotic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andreas Morguet Research Topics

Disease

1	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022
1	Neuralgia (Stump Neuralgia) 01/2021
1	Pain (Aches) 01/2021
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2019
1	Pulmonary Hypertension 01/2019
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 01/2019
1	Tuberculosis (Tuberculoses) 10/2015
1	Myxoma (Myxomas) 10/2015
1	Myocardial Infarction 12/2008
1	ST Elevation Myocardial Infarction 12/2008
1	Myocarditis (Carditis) 10/2008
1	Hyperemia 11/2007
1	Inflammation (Inflammations) 11/2007

Drug/Important Bio-Agent (IBA)

1	gadobutrolIBA 10/2022
1	FluoridesIBA 10/2022
1	cannabidivarinIBA 01/2021
1	CannabinoidsIBA 01/2021
1	4-S-(propionic acid)sulfidocyclophosphamide (PASP)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Abciximab (ReoPro)FDA Link 12/2008
1	Creatine Kinase (Creatine Phosphokinase)IBA 12/2008
1	CreatinineIBA 12/2008
1	EnzymesIBA 12/2008
1	Phosphotransferases (Kinase)IBA 12/2008
1	Biological ProductsIBA 10/2008
1	Antiviral Agents (Antivirals)IBA 10/2008
1	N(3)- (4- methoxyfumaroyl)- 2,3- diaminopropionic acidIBA 11/2007
1	Adenosine (Adenocard)FDA LinkGeneric 11/2007

Therapy/Procedure

1	Transcatheter Aortic Valve Replacement 01/2019
1	Intravenous Administration 12/2008
1	Therapeutics 12/2008
1	Percutaneous Coronary Intervention 12/2008
1	Catheters 11/2007